|
V88213
|
Metallo-β-lactamase-IN-13
|
1802366-23-9 |
Metallo-β-lactamase-IN-13 (Compound 13i) is a pan-metallo-β-lactamase inhibitor. |
|
V88216
|
Metallo-β-lactamase-IN-14
|
1802367-43-6 |
Metallo-β-lactamase-IN-14 (Compound 17e) is a Metallo-β-Lactamase inhibitor. |
|
V88214
|
Metallo-β-lactamase-IN-15
|
1804934-57-3 |
Metallo-β-lactamase-IN-15 (Compound ±13) is a potent MBL inhibitor with IC50 values of 0.29 μM, 0.088 μM and 0.063 μM for NDM-1, IMP-1 and VIM-2, respectively. |
|
V84317
|
N-Cbz-D-Cysteine (Cbz-D-Cys)
|
156916-81-3 |
|
|
V84188
|
N-Cbz-L-Cysteine (Cbz-cysteine)
|
53907-29-2 |
|
|
V10936
|
Cefuroxime Sodium
|
56238-63-2 |
Cefuroxime Sodium (Zinacef) is a 2nd-generation cephalosporin antibiotic used to treat and prevent a number of bacterial infections including pneumonia, meningitis, otitis media, sepsis, urinary tract infections, and Lyme disease. |